25.02.25 S&P 500-Papier Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor 3 Jahren verloren ...
Pfizer's disclosure Friday that it is ending global development and commercialization efforts for its hemophilia B treatment Beqvez brings an inauspicious ending to a gene therapy that got its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback